×
About 2,530 results

ALLMedicine™ Brugada Syndrome Center

Research & Reviews  891 results

Usefulness of insertable cardiac monitors for risk stratification: current indications ...
https://doi.org/10.1080/17434440.2023.2171862
Expert Review of Medical Devices; Assaf A, Theuns DA et. al.

Jan 26th, 2023 - : The 2018 ESC Syncope guidelines expanded the indications for an insertable cardiac monitor (ICM) to patients with unexplained syncope and primary cardiomyopathy or inheritable arrhythmogenic disorders. : This review article discusses the clinica...

ST Segment Elevation in a Young Woman with Metaplastic Breast Carcinoma.
https://doi.org/10.1536/ihj.22-345
International Heart Journal; Wieczorkiewicz P, Szymczyk K et. al.

Jan 23rd, 2023 - The 12-lead electrocardiogram (ECG) remains a key tool to diagnose ST elevation myocardial infarction (STEMI). However, a variety of other conditions aside from obstructive coronary disease, including hyperkalemia, myocarditis, pericarditis, and T...

Heart rate variability and microvolt T wave alternans changes during ajmaline test may ...
https://doi.org/10.1007/s10286-023-00922-4
Clinical Autonomic Research : Official Journal of the Cli... Călburean PA, Pannone L et. al.

Jan 17th, 2023 - Drug-induced type I Brugada syndrome (BrS) is associated with a ventricular arrhythmia (VA) rate of 1 case per 100 person-years. This study aims to evaluate changes in electrocardiographic (ECG) parameters such as microvolt T wave alternans (mTWA)...

Invasive and Clinical Features in Patients With Brugada Syndrome Undergoing Catheter Ablation
https://clinicaltrials.gov/ct2/show/NCT05685134

Jan 13th, 2023 - Brugada syndrome (BS) is an electric cardiac disorder characterized by a typical electrocardiographic pattern and an increased risk of cardiac arrhythmias and sudden death. Most arrhythmic events occur during rest, fever or under circumstances of ...

Risk stratification of sudden cardiac death in asymptomatic female Brugada syndrome pat...
https://doi.org/10.1111/anec.13030
Annals of Noninvasive Electrocardiology : the Official Jo... Leung KSK, Radford D et. al.

Jan 12th, 2023 - Risk stratification in Brugada syndrome remains a difficult problem. Given the male predominance of this disease and their elevated risks of arrhythmic events, affected females have received less attention. It is widely known that symptomatic pati...

see more →

Drugs  16 results see all →

Clinicaltrials.gov  40 results

Invasive and Clinical Features in Patients With Brugada Syndrome Undergoing Catheter Ablation
https://clinicaltrials.gov/ct2/show/NCT05685134

Jan 13th, 2023 - Brugada syndrome (BS) is an electric cardiac disorder characterized by a typical electrocardiographic pattern and an increased risk of cardiac arrhythmias and sudden death. Most arrhythmic events occur during rest, fever or under circumstances of ...

Brugada Syndrome Substrate Characterization and Ablation
https://clinicaltrials.gov/ct2/show/NCT05643209

Dec 15th, 2022 - Most of the patients with a diagnosis of Brugada syndrome (BrS) have no history of syncope or resuscitated cardiac arrest at the time of the diagnosis. Risk stratification in these patients is of utmost importance because cardiac arrest may be the...

Hearts in Rhythm Organization (HiRO)National Registry and Bio Bank
https://clinicaltrials.gov/ct2/show/NCT04189822

Nov 3rd, 2022 - Led by clinical researchers, HiRO is focused on identifying phenotype-genotype correlations. HiRO has defined the investigation pathway for patients with possible genetically mediated cardiac arrest, and has had major impact on our understanding o...

Impact on Risk Stratification of Overlap Syndrome Phenotype in Patients With E1784K Mutation in SCN5A
https://clinicaltrials.gov/ct2/show/NCT05274646

Oct 21st, 2022 - Study design: This study will compare the occurrence of MCE between patients with overlap syndrome phenotype and patients with a single phenotype (whether Brugada syndrome or Long QT syndrome type 3) in a cohort of patients 12 years of age and old...

Brugada Ablation of VF Substrate Ongoing MultiCenter Registry
https://clinicaltrials.gov/ct2/show/NCT04420078

Oct 7th, 2022 - Brugada syndrome (BrS) patients who undergo BRS substrate ablations from tertiary centers for catheter ablations of complex arrhythmias from three continents - Asia, Europe and North America - are registered in a common database. The investigators...

see more →

News  58 results

Don’t panic over lamotrigine, but beware of cardiac risks
https://www.mdedge.com/neurology/article/250030/epilepsy-seizures/dont-panic-over-lamotrigine-beware-cardiac-risks
Randy Dotinga

Dec 17th, 2021 - Despite a flurry of publicity about its newfound cardiac risk profile, the antiseizure medication lamotrigine (Lamictal) is “still a good drug” in epilepsy and an excellent treatment for certain groups, New York University neurologist Jacqueline A.

New Model Quantifies Cardiac Arrest Risk in Brugada Syndrome
https://www.staging.medscape.com/viewarticle/940327

Nov 4th, 2020 - NEW YORK (Reuters Health) - A new risk stratification model for patients with Brugada syndrome (BrS) is based on four risk factors for ventricular arrhythmias/sudden cardiac death (VA/SCD) and can inform the need for an implantable cardioverter de...

New Model Quantifies Cardiac Arrest Risk in Brugada Syndrome
https://www.medscape.com/viewarticle/940327

Nov 4th, 2020 - NEW YORK (Reuters Health) - A new risk stratification model for patients with Brugada syndrome (BrS) is based on four risk factors for ventricular arrhythmias/sudden cardiac death (VA/SCD) and can inform the need for an implantable cardioverter de...

Genomic Experts Throw Cold Water on Most Long QT Genes
https://www.staging.medscape.com/viewarticle/924411

Jan 28th, 2020 - Genomics experts say evidence falls short for more than half the genes published and anointed as causing long QT syndrome (LQTS) and assessed routinely on commercial genetic test panels. Of the 17 genes previously reported in the literature to cau...

Genomic Experts Throw Cold Water on Most Long QT Genes
https://www.medscape.com/viewarticle/924411

Jan 28th, 2020 - Genomics experts say evidence falls short for more than half the genes published and anointed as causing long QT syndrome (LQTS) and assessed routinely on commercial genetic test panels. Of the 17 genes previously reported in the literature to cau...

see more →

Patient Education  7 results see all →